Table 3.
Test performance for the diagnosis of active TB
| TST n (%)* (95% CI) |
Standard ELISpot† n (%)* (95% CI) |
Enhanced ELISpot† n (%)* (95% CI) |
|
|---|---|---|---|
| Sensitivity | |||
| Definite/probable TB‡ | 9/45 (20) (10–35) | 18/43 (42) (27–58) | 20/43 (45) (31–62) |
| Definite TB§ | 6/16 (38) (15–65) | 8/15 (53) (27–79) | 10/15 (67) (38–88) |
| Specificity | |||
| No TB¶ | 124/127 (98) (93–100) | 105/119 (88) (81–94) | 98/119 (82) (74–89) |
| Predictive values# | |||
| PPV | 9/12 (75) (43–95) | 18/32 (56) (38–74) | 20/41 (49) (33–65) |
| NPV | 124/160 (78) (70–84) | 105/130 (81) (73–87) | 98/121 (81) (73–88) |
All percentages rounded to the nearest whole number.
ELISpot was invalid in 7% (3/46) of children with TB and 6% (8/127) of those with no TB.
Proportion of children testing positive for a given test among those with culture-confirmed or clinically diagnosed TB.
Proportion of children testing positive for a given test among those with culture-confirmed TB only.
Proportion of children testing negative for a given test among those in whom TB was excluded.
Predictive values for definite/probable TB at baseline evaluation.
TB = tuberculosis; TST = tuberculin skin test; CI = confidence interval; ELISpot = enzyme linked immunospot based assay; PPV = positive predictive value; NPV = negative predictive value.